pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

University of Utah

updated 2mo ago

The University of Utah is a public research university in Salt Lake City, Utah, United States. It was established in 1850 as the University of Deseret by the General Assembly of the provisional State of Deseret, making it Utah's oldest institution of higher education. The university received its current name in 1892, four years before Utah attained statehood, and moved to its current location in 1900. It is the flagship university of the Utah System of Higher Education.

community read0 votes

🐶 often sniffed alongside

top 8
  • tagEndocrinology & Metabolism3 co-mentions · 3 sources
  • tagImmunology3 co-mentions · 3 sources
  • tagPD-12 co-mentions · 1 sources
  • tagInfectious Disease1 co-mentions · 1 sources
  • tagAlzheimer's Disease1 co-mentions · 1 sources
  • tagColorectal Cancer1 co-mentions · 1 sources
  • tagPulmonology1 co-mentions · 1 sources
  • tagOncology1 co-mentions · 1 sources
pipeline
1
marketed
0
phase 3
0
catalysts ytd
25
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Unknown: 1
1Unknown
drug
micronized progesterone

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase1Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancerrecruitingn=33
  • phase2Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutationsactive not recruitingn=14
  • phase2Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomasactive not recruitingn=1
  • phase2Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patientssuspendedn=50
  • —Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).recruitingn=50
  • phase2Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)not yet recruitingn=25
  • N/ACROS and Quality of Life of Elderly Cochlear Implant Recipients and Their Care Giverscompletedn=16
  • phase1Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis (RopeRux in Myelofibrosis)not yet recruitingn=15
more trials →
🐶 Hiring Signal
No open roles indexed yet — view University of Utah jobs →

News

  • There are already more U.S. measles cases this year than in all of 2025
    The number of measles cases in the U.S. has surpassed the record-breaking tally for all of 2025, with five more months of 2026 still to come.
    stat · 21d ago
  • Transformational Utah Investment in Artificial Intelligence and Computing to Advance Health and Discovery
    The State of Utah has made a visionary investment in AI and advanced computing infrastructure to advance research.
    onclive · 3mo ago
identifiers
source
globaldata
mentioned in
2news items
entity-linker matched
Data sources
openFDA
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?